Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping

Genes Chromosomes and Cancer

Volumn 37, Issue 3, 2003, Pages 252-260

  Pavlovich, Christian P ^a,b   Padilla Nash, Hesed ^a   Wangsa, Danny ^a   Nickerson, Michael L ^a   Matrosova, Vera ^a   Linehan, W Marston ^a   Ried, Thomas ^a   Phillips, John L ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME BANDING PATTERN; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; KARYOTYPING; KIDNEY CARCINOMA; MET GENE; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; VHL GENE;

ADENOCARCINOMA, CLEAR CELL; ANEUPLOIDY; CARCINOMA, RENAL CELL; CHROMOSOME DELETION; CHROMOSOME PAINTING; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, TUMOR SUPPRESSOR; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; LIGASES; MALE; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; PROTO-ONCOGENE PROTEINS C-MET; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0038546730     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10209     Document Type: Article

References (32)

1. Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, Imreh S, Klein G, Zabarovsky ER. 2000. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene 19:1392-1399.
2. Amare Kadam PS, Varghese C, Bharde SH, Narasimhamoorthy NK, Desai S, Advani SH, Havaldar R, Kulkarni JN. 2001. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7. Cancer Genet Cytogenet 125:139-146.
3. Anglard P, Trahan E, Liu S, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM. 1992. Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res 52:348-356.
4. Barch M, Knutsen T, Spurbeck J. 1997. The AGT cytogenetic laboratory manual. Philadelphia: Lippincott/Raven.
5. Beroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chretien Y, Marechal JM, Weissenbach J, Junien C. 1996. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosomes Cancer 17:215-224.
6. Bugert P, Pesti T, Kovacs G. 2000. The tcf17 gene at chromosome 5q is not involved in the development of conventional renal cell carcinoma. Int J Cancer 86:806-810.
7. Cawkwell L, Bell SM, Lewis FA, Dixon MF, Taylor GR, Quirke P. 1993. Detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 67:1262-1267.
8. Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER. 1998. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 22:200-209.
9. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh F-M, Lubensky IA, Duan R, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Issacs WB, Lerman MI, Zbar B, Linehan WM. 1994. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85-90.
10. Gunawan B, Huber W, Holtrup M, von Heydebreck A, Efferth T, Poustka A, Ringert RH, Jakse G, Fuzesi L. 2001. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res 61:7731-7738.
11. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, Baylin S. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704.
12. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
13. Knutsen T, Ried T. 2000. SKY: a comprehensive diagnostic and research tool. A review of the first 300 published cases. J Assoc Genet Tech 26:3-15.
14. Kovacs G, Frisch S. 1989. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 49:651-659.
15. Kovacs G, Kung HF. 1991. Nonhomologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci USA 88:194-198.
16. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DSR, Dean M, Glavac D, Richards FM, Crossey PA, Fergusin-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320.
17. Macville M, Schröck E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N, Ried T. 1999. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 59:141-150.
18. Moch H, Presti JC Jr, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM. 1996. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56:27-30.
19. Nickerson ML, Weirich G, Zbar B, Schmidt LS. 2000. Signaturebased analysis of MET proto-oncogene mutations using DHPLC. Hum Mutat 16:68-76.
20. Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther MM, Linehan WM, Klausner RD, Ried T. 2001. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau (VHL) disease with spectral karyotyping (SKY). Genes Chromosomes Cancer 31:1-9.
21. Presti JC Jr, Moch H, Gelb AB, Huynh D, Waldman FM. 1998. Initiating genetic events in small renal neoplasms detected by comparative genomic hybridization. J Urol 160:1557-1561.
22. Presti JC Jr, Wilhelm M, Reuter V, Russo P, Motzer R, Waldman F. 2002. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney. J Urol 167:1464-1468.
23. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. 1993. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53:3092-3097.
24. Reutzel D, Mende M, Naumann S, Störkel S, Brenner W, Zabel B, Decker J. 2001. Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization. Cytogenet Cell Genet 93:221-227.
25. Ried T, Liyanage M, du Manoir S, Heselmeyer K, Auer G, Macville M, Schröck E. 1997. Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J Mol Med 75:801-814.
26. Ried T, Heselmeyer-Haddad K, Blegen H, Schröck E, Auer G. 1999. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195-204.
27. Schmidt L, Duh F-M, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky IA, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis TJ, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJM, Walther MM, Tsui L, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Störkel S, Lerman MI, Linehan WM, Zbar B. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet 16:68-73.
28. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter, DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolor spectral karyotyping of human chromosomes. Science 273:494-497.
29. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R, Linehan WM. 1998. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12:417-423.
30. Yang ZQ, Yoshida MA, Fukuda Y, Kurihara N, Nakamura Y, Inazawa J. 2000. Molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas. Jpn J Cancer Res 91:156-163.
31. Zhao WP, Gnarra JR, Liu S, Knutsen T, Linehan WM, Whang-Peng J. 1995. Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines. Cancer Genet Cytogenet 82:128-139.
32. Zhuang Z. Park WS, Pack S, Schmidt L, Vortmeyer AO, Pak E, Pham T, Weil RJ, Candidus S, Lubensky IA, Linehan WM, Zbar B, Weirich G. 1998. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat Genet 20:66-69.